Vimta Labs Share Price

Vimta Labs Limited., established in 1984, is Indias most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and nonGLP), clinical research, central lab, and cGMP as well as nonGMP analytical services for pharmaceutical and biopharmaceutical companies Preclinical research and testing services for medical device companies Contract research and testing for Agroscience companies Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil gas, mining etc EMI/EMC testing for electronic and electrical products.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.During the year 200607, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.In 202425, Emtac Laboratories Pvt. Ltd., the 100% owned subsidiary got merged with the Company effective from 01 April, 2024, thereby consolidating its presence in the Electronics and Electrical testing.

Vimta Labs reported a Q3FY25 revenue of ₹89.92 crore, up 0.2% YoY, with net profit decreased -14.9% to ₹17.52 crore. For the full year FY2024–2025, revenue reached ₹322.27 crore and profit touched at ₹41.01 crore. As of Jun '25, Vimta Labs’s market capitalisation stood at ₹2,960.51 crores. Shareholding as of Jun '25 shows promoters holding 36.7%, with FIIs at 3.5%, DIIs at 58.4%, and public at %.

As of 20 Aug, 2025, Vimta Labs share price is ₹685.6. The stock opened at ₹669.8 and had closed at ₹665.2 the previous day. During today’s trading session, Vimta Labs share price moved between ₹663.10 and ₹692.95, with an average price for the day of ₹678.03. Over the last 52 weeks, the stock has recorded a low of ₹245.65 and a high of ₹728.45. In terms of performance, Vimta Labs share price has increased by 45.1% over the past six months and has increased by 166.00% over the last year.